摘要
Circulating and podocyte-bound urokinase receptor (uPAR) is a mediator of podocyte injury, proteinuria, and focal segmental glomerulosclerosis (FSGS) allowing pathological activation of the uPAR-beta 3 integrin signaling axis. Clinically, calcineurin inhibitors (e.g., cyclosporine A, CsA) are known to suppress T cells, yet are also being used to reduce proteinuria in FSGS, suggesting the possibility of signal cross talk between uPAR and calcineurin. Calcineurin is known to facilitate the nuclear translocation of the nuclear factor of activated T cells (NFAT). Accordingly, in vivo conditional NFATc1 activation in podocytes leads to proteinuria in mice, yet the downstream targets of NFAT remain unclear. Here, we show that inducible podocyte-specific expression of constitutively active NFATc1 increased podocyte uPAR expression by binding to the Plaur gene promoter (encoding uPAR) in chromatin immunoprecipitation assays. Pathological uPAR signals in podocytes are independent of T cells and affect cell motility via activation, but not expression, changes of the beta 3 integrin and can be blocked by CsA, NFAT-siRNA, or the cell-permeable NFAT inhibitor (11R-VIVIT) using rodent models of glomerular disease (LPS; 5/6 nephrectomized rats). Taken together, these findings identify podocyte uPAR as a downstream target of NFAT and provide further insights into the pathogenesis of FSGS.
学科与关键词
- Amiloride off-target effect inhibits podocyte urokinase receptor expression and reduces proteinuriaZhang Bin; Xie Shaoting; Shi Wei*; Yang YunNephrology Dialysis Transplantation, 2012, 27(5): 1746-1755.被引 21
- 1,25-Dihydroxyvitamin D(3) Inhibits Podocyte uPAR Expression and Reduces ProteinuriaMa Jianchao; Zhang Bin; Liu Shuangxin; Xie Shaoting; Yang Yun; Ma Juan; Deng Yujun; Wang Wenjian; Xu Lixia; Li Ruizhao; Zhang Li; Yu Chunping; Shi Wei*PLoS ONE, 2013, 8(5): e64912.被引 1
- Activation of necroptosis pathway in podocyte contributes to the pathogenesis of focal segmental glomerular sclerosisHu, Haoqiang; Li, Mengyuan; Chen, Binfeng; Guo, Chaohuan; Yang, Niansheng*Clinical and Experimental Nephrology, 2022, 26(11): 1055-1066.被引 4
